<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03551236</url>
  </required_header>
  <id_info>
    <org_study_id>VCS-001</org_study_id>
    <nct_id>NCT03551236</nct_id>
  </id_info>
  <brief_title>Variability of Impedance Pneumography Tidal Breathing Flow-volume Curves During Sleep in Healthy Children</brief_title>
  <official_title>Variability of Impedance Pneumography Tidal Breathing Flow-volume Curves During Sleep in Healthy Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Revenio Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital Srebrnjak</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Revenio Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study for the assessment of normal overnight variation in small&#xD;
      healthy children using the Ventica Lung Function Testing System. The study is carried out to&#xD;
      establish reference ranges for overnight lung function variation using the Ventica test, and&#xD;
      to assess the impact of the demographic factors on the Ventica results.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 17, 2017</start_date>
  <completion_date type="Actual">July 3, 2017</completion_date>
  <primary_completion_date type="Actual">July 3, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Normal range of variables of tidal breathing flow-volume curves (CSRmin, NLmin, etc.)</measure>
    <time_frame>1-3 nights per subject</time_frame>
    <description>Analyse the normal range of variables that describe the shape and variability of tidal breathing flow-volume curves during natural night sleep obtained with impedance pneumography</description>
  </primary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Healthy Subjects</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Young children screened to have small probability of asthma or wheezing&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 months-6 years, both sexes&#xD;
&#xD;
          -  Healthy at the time of inclusion&#xD;
&#xD;
          -  Laboratory analyses in the reference range or not clinically relevant according to the&#xD;
             investigator judgement&#xD;
&#xD;
          -  Lung function in the reference range with a negative bronchodilator test result&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preterm birth&#xD;
&#xD;
          -  Chronic respiratory disorder of prematurity&#xD;
&#xD;
          -  Recurrent bronchitis or recurrent hospitalizations because of a respiratory illness&#xD;
             (recurrent pneumonia)&#xD;
&#xD;
          -  Primary immunodeficiency&#xD;
&#xD;
          -  Chronic rhinosinusitis, synonasal polyposis&#xD;
&#xD;
          -  Nasal congestion, adenotonsillar hypertrophy, signs and symptoms of sleep apnea or&#xD;
             sleep disordered breathing&#xD;
&#xD;
          -  Acute respiratory infection or hospitalization because of an acute illness within 4&#xD;
             weeks prior to inclusion&#xD;
&#xD;
          -  Personal or family history or clinical evidence of asthma, atopy or other chronic&#xD;
             respiratory disorders (high risk for asthma and allergy)&#xD;
&#xD;
          -  Use of asthma rescue or maintenance medication within 4 weeks prior to inclusion&#xD;
&#xD;
          -  Implanted or external active medical devices such as pacemakers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Davor Plavec, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Srebrnjak</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Srebrnjak</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 28, 2018</study_first_submitted>
  <study_first_submitted_qc>May 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2018</study_first_posted>
  <last_update_submitted>May 28, 2018</last_update_submitted>
  <last_update_submitted_qc>May 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

